“…Even though FBA is a relatively recently developed method, it has proven to be a favourable technique to examine white matter properties in several studies. It has already been used in a range of different clinical groups (including Parkinson's disease (Rau et al, 2019), traumatic brain injury (Verhelst et al, 2019), stroke (Egorova et al, 2020), multiple sclerosis (Gajamange et al, 2018), depression (Lyon et al, 2019), autism spectrum disorder (Dimond et al, 2019), and Alzheimer's disease (Mito et al, 2018)) and in healthy cohorts (Choy et al, 2020;Dimond et al, 2020;Genc et al, 2018).…”